Immuno-localization of CD44 and osteopontin in developing human kidney

Pediatric Research

Volumn 65, Issue 1, 2009, Pages 79-84

  Crisi, Giovanna M ^a   Marconi, Sharon A ^a   Rockwell, Gary F ^a   Braden, Gregory L ^a   Campfield, Thomas J ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b Newborn Medicine W2810   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; HERMES ANTIGEN; OSTEOPONTIN;

ARTICLE; BRANCHING MORPHOGENESIS; DIFFERENTIATION; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; KIDNEY DEVELOPMENT; KIDNEY DISTAL TUBULE; KIDNEY EPITHELIUM; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; MALE; NEPHRON; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; URETER;

ANTIGENS, CD44; EPITHELIUM; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TUBULES; MORPHOGENESIS; NEPHRONS; ORGANOGENESIS; OSTEOPONTIN; URETER;

EID: 58149378132     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31818912b7     Document Type: Article

References (44)

1. Hein G, Richter D, Manz F, Weitzel D, Kalhoff H 2004 Development of nephrocalcinosis in very low birth weight infants. Pediatr Nephrol 19:616-620
2. Campfield T, Braden G, Flynn-Valone P, Clark N 1994 Urinary oxalate excretion in premature infants: effect of human milk versus formula feeding. Pediatrics 94:674-678
3. Kist-van Holthe JE, van Zwieten PH, Schell-Feith EA, Zonderland HM, Holscher HC, Wolterbeek R, Veen S, Frolich M, van der Heijden BJ 2007 Is nephrocalcinosis in preterm neonates harmful for long-term blood pressure and renal function? Pediatrics 119:468-475
4. Ezzedeen F, Adelman RD, Ahlfors CE 1988 Renal calcification in preterm infants: pathophysiology and long-term sequelae. J Pediatr 113:532-539
5. Clark AT, Bertram JF 1999 Molecular regulation of nephron endowment. Am J Physiol 276:F485-F497
6. Hershkovitz D, Burbea Z, Skorecki K, Brenner BM 2007 Fetal programming of adult kidney disease: cellular and molecular mechanisms. Clin J Am Soc Nephrol 2:334-342
7. Günthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P 1991 A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24
8. Goodison S, Urquidi V, Tarin D 1999 CD44 cell adhesion molecules. Mol Pathol 52:189-196
9. Nagano O, Saya H 2004 Mechanism and biological significance of CD44 cleavage. Cancer Sci 95:930-935
10. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U 1994 Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71-82
11. Wuthrich RP 1999 The proinflammatory role of hyaluronan-CD44 interactions in renal injury. Nephrol Dial Transplant 14:2554-2556
12. Lewington AJ, Padanilam BJ, Martin DR, Hammerman MR 2000 Expression of CD44 in kidney after ischemic injury in rats. Am J Physiol Regul Integr Comp Physiol 278:R247-R254
13. Benz PS, Fan X, Wüthrich RP 1996 Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis. Kidney Int 50:156-163
14. Sibalic V, Fan X, Loffing J, Wüthrich RP 1997 Upregulated renal tubular CD44, hyaluronan, and osteopontin in kdkd mice with interstitial nephritis. Nephrol Dial Transplant 12:1344-1353
15. Florquin S, Nunziata R, Claessen N, van den Berg FM, Pals ST, Weening JJ 2002 CD44 expression in IgA nephropathy. Am J Kidney Dis 39:407-414
16. Rouschop KM, Roelofs JJ, Sylva M, Rowshani AT, Ten Berge IJ, Weening JJ, Florquin S 2006 Renal expression of CD44 correlates with acute renal allograft rejection. Kidney Int 70:1127-1134
17. Pohl M, Sakurai H, Stuart RO, Nigam SK 2000 Role of hyaluronan and CD44 in in vitro branching morphogenesis of ureteric bud cells. Dev Biol 224:312-325
18. Pohl M, Stuart RO, Sakurai H, Nigam SK 2000 Branching morphogenesis during kidney development. Ann Rev Physiol 62:595-620
19. Piscione TD, Rosenblum ND 2002 The molecular control of renal branching morphogenesis: current knowledge and emerging insights. Differentiation 70:227-246
20. Chen Y, Bal BS, Gorski JP 1992 Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Biol Chem 267:24871-24878
21. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B 1990 CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313
22. Verkoelen CF, van der Boom BG, Romijn JC 2000 Identification of hyaluronan as a crystal-binding molecule at the surface of migrating and proliferating MDCK cells. Kidney Int 58:1045-1054
23. Verhulst A, Asselman M, de Naeyer B, Vervaet BA, Mengel M, Gwinner W, D'Haese PC, Verkoelen CF, de Broe ME 2005 Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis. Kidney Int 68:1643-1647
24. Genest DR, Williams MA, Greene MF 1992 Estimating the time of death in stillborn fetuses. I. Histologic evaluation of fetal organs; an autopsy study of 150 stillborns. Obstet Gynecol 80:575-584
25. Fleming S, Lindop GB, Gibson AA 1985 The distribution of epithelial membrane antigen in the kidney and its tumours. Histopathology 9:729-739
26. Merkel CE, Kamer CM, Carroll TJ 2007 Molecular regulation of kidney development: is the answer blowing in the Wnt? Pediatr Nephrol 22:1825-1838
27. Rosines E, Schmidt HJ, Nigam SK 2007 The effect of hyaluronic acid size and concentration on branching morphogenesis and tubule differentiation in developing kidney culture systems: potential applications to engineering of renal tissues. Biomaterials 28:4806-4817
28. Rouschop KM, Sewnath ME, Claessen N, Roelofs JJ, Hoedemaeker I, van der Neut R, Aten J, Pals SJ, Weening JJ, Florquin S 2004 CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 15:674-686
29. Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, Stamenkovic I, Biancone L, Camussi G 2007 Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 72:430-441
30. Denda S, Reichardt LF, Müller U 1998 Identification of OPN as a novel ligand for the integrin alpha8 beta1 and potential roles for the integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell 9:1425-1435
31. Nomura S, Wills AJ, Edwards DR, Heath JK, Hogan BL 1988 Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 106:441-450
32. Rogers SA, Padanilam BJ, Hruska KA, Giachelli CM, Hammerman MR 1997 Metanephric osteopontin regulates nephrogenesis in vitro. Am J Physiol 272:F469-F476
33. Hudkins KL, Gianchelli CM, Cui Y, Couser WG, Johnson RJ, Alpers CE 1999 Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol 10:444-457
34. Verhulst A, Persy VP, van Rompay AR, Verstrepen WA, Helbert MF, de Broe ME 2002 Osteopontin synthesis and localization along the human nephron. J Am Soc Nephrol 13:1210-1218
35. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F 2001 Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60:1645-1657
36. Fischer JW, Tschöpe C, Reinecke A, Giachelli CM, Unger T 1998 Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Diabetes 47:1512-1518
37. Kelly DJ, Wilkinson-Berka JL, Ricardo SD, Cox AJ, Gilbert RE 2002 Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-27) rats. Nephrol Dial Transplant 17:985-991
38. Yu XQ, Wu LL, Huang XR, Yang N, Gilbert RE, Cooper ME, Johnson RJ, Lai KN, Lan HY 2000 Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. Kidney Int 58:1469-1480
39. Alchi B, Nishi S, Kondo D, Kaneko Y, Matsuki A, Imai N, Ueno M, Iguchi S, Sakatsume M, Narita I, Yamamoto T, Gejyo F 2005 Osteopontin expression in acute renal allograft rejection. Kidney Int 67:886-896
40. Hudkins KL, Le QC, Segerer S, Johnson RJ, Davis CL, Giachelli CM, Alpers CE 2001 Osteopontin expression in human cyclosporine toxicity. Kidney Int 60:635-640
41. Rockwell GF, Morgan MJ, Braden G, Campfield TJ 2008 Preliminary observations of urinary calcium and osteopontin excretion in premature infants, term infants and adults. Neonatology 93:241-245
42. Verkoelen CF, van der Boom BG, Houtsmuller AB, Schröder FH, Romijn JC 1998 Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. Am J Physiol 274:F958-F965
43. Asselman M, Verhulst A, de Broe ME, Verkoelen CF 2003 Calcium oxalate crystal adherence to hyaluron-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol 14:3155-3166
44. Verhulst A, Asselman M, Persy VP, Schepers MS, Helbert MF, Verkoelen CF, de Broe ME 2003 Crystal retention capacity of cells in the human nephron: involvement of CD44 and its ligands hyaluronic acid and osteopontin in the transition of a crystal-binding into a nonadherent epithelium. J Am Soc Nephrol 14:107-115